+0.92%
Today
Loading 1D prices…
Company profile
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Parsippany, NJ, United States
Employees
1.9K
Fiscal year end
0930
CIK
1872789
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ANIKAnika Therapeutics Inc. Common Stock | $279.2M | $112.8M | -9.75% | -$0.76 | -0.62% | Buy |
| TLSITriSalus Life Sciences Inc. Common Stock | $287.2M | $45.2M | -86.88% | -$1.84 | -0.74% | Buy |
| TMCITreace Medical Concepts Inc. Common Stock | $293.3M | $212.7M | -27.74% | -$0.93 | +4.14% | Hold |
| RCELAvita Medical Inc. Common Stock | $305.6M | $71.6M | -67.85% | -$1.74 | +0.20% | Buy |
| INFUInfuSystems Holdings Inc. Common Stock | $242M | $143.4M | +4.62% | $0.31 | +0.12% | Buy |